NDC 63323-762-17 - Topotecan Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-762
- Requested NDC
- 63323-762-17
- Package NDCs from labels
- 63323-762-10, 63323-762-94, 63323-762-17
- Manufacturer
- Fresenius Kabi USA, LLC | ScinoPharm Taiwan, Ltd.
- Effective date
- 2026-01-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Topotecan Hydrochloride - Fresenius Kabi USA, LLC | ScinoPharm Taiwan, Ltd. | Fresenius Kabi USA, LLC | ScinoPharm Taiwan, Ltd. | 2026-01-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Topotecan Hydrochloride - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2025-11-27 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-762-10 | Topotecan Hydrochloride | 1 in 1 BOX | INJECTION, POWDER, LYOPHILIZED, | 1 | 15 | |
| 63323-762-10 | Topotecan Hydrochloride | 4 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 4 | 15 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-762 | TOPOTECAN HYDROCHLORIDE (TOPOTECAN HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC ] | 14 | Current NDC, Legacy NDC, 2 package rows | 20240724_b6019088-cd94-43b4-b5ce-ba20b6b8021e.zip |
| 63323-762 | TOPOTECAN HYDROCHLORIDE (TOPOTECAN HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC ] | 4 | Current NDC, Legacy NDC | 20210626_b094e6ba-7cf6-4fb8-8683-73d324650dd3.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-762-10 | EA - Each | 63323-762 | 1018eb56-e99d-4b4f-b87f-c915aecdf76b | 1 | 2013-02-13 |
| 63323-762-17 | EA - Each | 63323-762 | 723c6eb3-565a-46be-9f37-694c0d613cdc | 1 | 2013-02-13 |
| 63323-762-94 | EA - Each | 63323-762 | a90264b3-9d81-424e-90c6-05d7165e2583 | 1 | 2013-09-04 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| TOPOTECAN HYDROCHLORIDE | ACTIVE INGREDIENT | 956S425ZCY | TOPOTECAN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| TOPOTECAN | ACTIVE MOIETY | 7M7YKX2N15 | TOPOTECAN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | TOPOTECAN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | TOPOTECAN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | TOPOTECAN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| TARTARIC ACID | INACTIVE INGREDIENT | W4888I119H | TOPOTECAN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BM BM182 DROPS | HEPAR SULF, GRAPHITES, MERC SOL, MURIATIC ACID | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5423bde6-3e31-38b0-e063-6294a90afb2d | 2026-06-13 | Warnings | QTT17582CB |
| BM BM182 DROPS | HEPAR SULF, GRAPHITES, MERC SOL, MURIATIC ACID | BM Private Limited | 540d11e3-e4a1-0ca2-e063-6394a90a3c26 | 2026-06-12 | Warnings | QTT17582CB |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 8643bc58-bb0e-5c79-e053-2991aa0a02ae | 2026-05-19 | Warnings | QTT17582CB |
| 8e14e597-acf1-4799-a419-397d311ecce0 | b094e6ba-7cf6-4fb8-8683-73d324650dd3 | 2026-04-30 | Boxed warning, Warnings, Adverse reactions | b094e6ba-7cf6-4fb8-8683-73d324650dd3 | ||
| Mannitol | MANNITOL | Hospira, Inc. | 8ad3145e-00e7-4412-b9a5-06f00f264f30 | 2026-04-21 | Warnings, Adverse reactions | 3OWL53L36A |
| Joint Tonic R II | HARPAGOPHYTUM PROCUMBENS, SALIX ALBA, COLCHICUM AUTUMNALE, PINUS SYLVESTRIS, SYMPHYTUM OFFICINALE, ACONITUM NAPELLUS, ARNICA MONTANA, GELSEMIUM SEMPERVIRENS, IRIS VERSICOLOR, LEDUM PALUSTRE, LESPEDEZA CAPITATA, RHUS TOX, SECALE CORNUTUM, SPIGELIA ANTHELMIA, SPIRAEA ULMARIA, TARTARICUM ACIDUM | BioActive Nutritional, Inc. | 77afccf5-4e9c-45a1-8a6a-e686bcf22f16 | 2026-04-17 | Warnings | W4888I119H |
| Skin Irritations and Itch Relief | AGARICUS MUSCARIUS, ALUMINA, ANAGALLIS ARVENSIS, ANTIMONIUM TARTARICUM, APIS MELLIFICA, ARSENICUM ALBUM, ARSENICUM IODATUM, BOVISTA, CAUSTICUM, DOLICHOS PRURIENS, FAGOPYRUM ESCULENTUM, GRAPHITES, KALI MURIATICUM, MURIATICUM ACIDUM, OLEANDER, PETROLEUM, PIX LIQUIDA, RADIUM BROMATUM (12X, 30X, 1LM), RHUS TOX, SELENIUM METALLICUM, SULPHUR AND URTICA URENS. | King Bio Inc. | d139d2f1-0369-4963-9f3d-c4cc0f1ea2dd | 2026-03-10 | Warnings | QTT17582CB |
| Topotecan Hydrochloride | TOPOTECAN HYDROCHLORIDE | Fresenius Kabi USA, LLC | b6019088-cd94-43b4-b5ce-ba20b6b8021e | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | ANDA091089 63323-762-10 63323-762 1799416 7f91362f-6b55-4518-b034-b54aa5881204 b6019088-cd94-43b4-b5ce-ba20b6b8021e 956S425ZCY |
| Endotoxin Terrain Drops 2143 | ENDOTOXIN TERRAIN DROPS | Professional Complementary Health Formulas | 58842566-005a-48b5-973d-20cde2fbd701 | 2026-01-08 | Warnings | QTT17582CB |
| Abdominal Pain Drops 2051 | ABDOMINAL PAIN DROPS | Professional Complementary Health Formulas | f1b1dde6-bb37-4774-a58c-b4f648f9c2b5 | 2026-01-08 | Warnings | QTT17582CB |
| Hemorrhoid | AESCULUS HIPP, HAMAMELIS, ALOE, CALC PHOS, CARBO AN, CARBO VEG, LACHESIS, LYCOPODIUM, MURIATICUM AC, NITRICUM AC, NUX VOM, PAEONIA, RATANHIA, SEPIA, SULPHUR | Natural Creations, Inc | db1b3aef-ba92-417c-b6f6-58e950ed4214 | 2025-12-16 | Warnings | QTT17582CB |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 8f8f53e3-fe31-e7b5-e053-2995a90a710d | 2025-11-14 | Warnings | 3OWL53L36A |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 9984a510-30be-4013-e053-2995a90a841e | 2025-11-14 | Warnings | 3OWL53L36A |
| Mannitol | MANNITOL | ProPharma Distribution | 430669d7-9ad1-9a04-e063-6394a90ababb | 2025-11-07 | Warnings, Adverse reactions | 3OWL53L36A |
| Sorbitol-Mannitol | SORBITOL AND MANNITOL | ICU Medical Inc. | 5b44e248-4b7b-4777-954a-921c7b309944 | 2025-10-30 | Warnings, Adverse reactions | 3OWL53L36A |
| Mannitol | MANNITOL | ICU Medical Inc. | ba7bf864-8a4d-4262-8fd1-00174fa2f9d1 | 2025-10-24 | Warnings, Adverse reactions | 3OWL53L36A |
| Osmitrol | MANNITOL | Baxter Healthcare Company | 0d914965-7001-45cb-ba51-d7c5964b05bc | 2025-08-26 | Warnings, Adverse reactions | 3OWL53L36A |
| Aller-Chord F | ACETALDEHYDE, ACETICUM AC, ARG NIT, CAFFEINUM, CALC SULPH, CITRICUM AC, CORTISONE ACETICUM, ECHINACEA PURP, FOLLICULINUM, FRAGARIA, FUMARICUM AC, GALLICUM AC, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, HISTAMINUM HYDROCHLORICUM, HYDRANGEA, LAC VAC, LECITHIN, LIMULUS, LYCOPERSICUM, LYCOPODIUM, NAT BICARB, NAT MUR, NUX VOM, PARAFFINUM, PHOSPHORICUM AC, SACCHARUM OFF, SILICEA, TARTARICUM AC, TORULA CEREVISIAE. | Energetix Corporation | ff4eb7b2-8272-4bd3-99a9-7e589b30d59a | 2025-07-15 | Warnings | W4888I119H |
| Mannitol | MANNITOL | Henry Schein, Inc. | e2444db1-9dfe-451f-a33c-9b00786464d2 | 2025-05-20 | Warnings, Adverse reactions | 3OWL53L36A |
| Bestmade Natural Products BM182 Pellets | GRAPHITES, HEPAR SULF, MERC SOL, MURIATIC ACID | Bestmade Natural Products | 3242e013-2952-2b56-e063-6294a90a1693 | 2025-04-08 | Warnings | QTT17582CB |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.